| Literature DB >> 16759762 |
Lisa F Shubitz1, Jieh-Juen Yu, Chiung-Yu Hung, Theo N Kirkland, Tao Peng, Robert Perrill, Julie Simons, Jianmin Xue, Roger A Herr, Garry T Cole, John N Galgiani.
Abstract
Two recombinant antigens which individually protect mice from lethal intranasal infection were studied in combination, either as a mixture of two separately expressed proteins or as a single chimeric expression product. Mice vaccinated with either combination survived longer than mice given single antigens. Immunized mice also exhibited specific IgG immunoglobulins and yielded splenocytes which produced interferon-gamma in response to either antigen. The chimeric antigen has the practical advantage of offering enhanced protection from multiple components without increasing production costs.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16759762 DOI: 10.1016/j.vaccine.2006.04.002
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641